Pilot Study of Extracorporeal Removal of Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia

Ravi Thadhani; Tuelay Kisner; Henning Hagmann; Verena Boßung; Stefanie Noack; W Schaarschmidt; A Jank; Angela Kribs; Oliver A. Cornely; Claudia Kreyssig; Linda Hemphill; Alan C. Rigby; Santosh A. Khedkar; Tom H. Lindner; Peter Mallmann; Holger Stepan; S. Ananth Karumanchi; Thomas Benzing

doi:10.1161/circulationaha.111.034793

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

This pilot study supports the hypothesis that extracorporeal apheresis can lower circulating sFlt-1 in very preterm preeclampsia. Further studies are warranted to determine whether this intervention safely and effectively prolongs pregnancy and improves maternal and fetal outcomes in this setting.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Thadhani et al. (2011) studied this question.

synapsesocial.com/papers/69d9b7f60d540cafc58373c3 https://doi.org/10.1161/circulationaha.111.034793

View Full Paper

Ask AI

Bookmark

Share

Pilot Study of Extracorporeal Removal of Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia

Ask about this paper

Abstract

Discussion

Cite This Study

Pilot Study of Extracorporeal Removal of Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading